DocDollars

Dendreon Pharmaceuticals LLC

CA · United States · Reporting entity ID 100000196774

Total reported 2019–2025
$16.3M
#363 of 2,960 reporting companies — 0% of all reported industry payments
$4.32M in general payments across 56,598 records, plus $12.0M in research funding across 1,913 records.

How it breaks down

General payments $4,319,800
Research funding $12,001,253

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Dendreon Pharmaceuticals LLC reported $16.3M to US doctors and teaching hospitals from 2019 to 2025, ranking #363 of 2,960 reporting companies. 74% of that was research funding and 26% general payments such as consulting, speaking, food and travel. 56,598 general payment records and 1,913 research records were filed.

Common questions about Dendreon Pharmaceuticals LLC

How much has Dendreon Pharmaceuticals LLC paid US doctors?

Dendreon Pharmaceuticals LLC reported $16,321,052 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $4,319,800 in general payments, $12,001,253 in research funding.

How does Dendreon Pharmaceuticals LLC rank among drug and device companies?

It ranks #363 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Dendreon Pharmaceuticals LLC mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.